Angiogenic Switch in Multiple Myeloma

References

• Carmeliet, P. (2003) "Angiogenesis in health and disease", Nat. Med. 9, 653–660.
   PubMed Web of Science ®Google Scholar
• Conway, EM., Collen, D. and Carmeliet, P. (2001) "Molecular mechanisms of blood vessel growth", Cardiovasc. Res. 49, 507–521.
   PubMed Web of Science ®Google Scholar
• Kerbel, R.S. (2000) "Tumor angiogenesis: past, present and the near future", Carcinogenesis 21, 505–515.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P. and Jain, R.K. (2000) "Angiogenesis in cancer and other diseases", Nature 407, 249–257.
   PubMed Web of Science ®Google Scholar
• Bergers, G. and Benjamin, L.E. (2003) "Tumorigenesis and the angiogenic switch", Nature Rev. Cancer 3, 401–410.
   PubMed Web of Science ®Google Scholar
• Papetti, M. and Herman, I.M. (2001) "Mechanism of normal and tumor-derived angiogenesis", Am. J. Physiol Cell Physiol. 282, 947–970.
   Web of Science ®Google Scholar
• Ferrara, N., Gerber, H.P. and LeCouter, J. (2003) "The biology of VEGF and its receptors", Nat. Med. 9, 669–676.
   PubMed Web of Science ®Google Scholar
• Tjwa, M., Luttun, A., Autiero, M. and Carmeliet, P. (2003) "VEGF and P1GF: two pleiotropic growth factors with distinct roles in development and homeostasis", Cell Tissue Res. 314, 5–14.
   PubMed Web of Science ®Google Scholar
• Holash, J., Wiegand, S.J. and Yancopoulos, G.D. (1999) "New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angio-poietins and VEGF", Oncogene 18, 5356–5362.
   PubMed Web of Science ®Google Scholar
• Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, Di., Jain, V, Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C. and Yancopoulos, G.D. (1996) "Isolation of angiopoietin-1, a ligand for the 11E2 receptor, by secretion-trap expression cloning", Cell 87, 1161–1169.
   PubMed Web of Science ®Google Scholar
• Kwak, H.J., So, J.N., Lee, S.J., Kim, I. and Koh, G.Y. (1999) "Angiopoietin-1 is an apoptosis survival factor for endo-thelial cells", FEBS Lett. 448, 249–253.
   PubMed Web of Science ®Google Scholar
• Papapetropoulos, A., Garcia-Cardena, G., Dengler, T.J., Maisonpierre, P.C., Yancopoulos, G.D. and Sessa, W.C. (1999) "Direct actions of angiopoietin-1 on human endo-thelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors", Lab. Invest. 79, 213–223.
   PubMed Web of Science ®Google Scholar
• Hayes, A.J., Huang, W.Q., Mallah, J., Yang, D., Lippman, M.E. and Li, L.Y. (1999) "Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells", Microvasc. Res. 58,224–237.
   PubMed Web of Science ®Google Scholar
• Tsigkos, S., Koutsilieris, M. and Papapetropoulos, A. (2003) "Angiopoietins in angiogenesis and beyond", Expert Opin. Investig. Drugs 12, 933–941.
   PubMed Web of Science ®Google Scholar
• Maisonpierre, P.C., Sun, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1997) "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis", Science 277, 55–60.
   PubMed Web of Science ®Google Scholar
• Moehler, TM., Ho, AD., Goldschmidt, H. and Barlogie, B. (2003) "Angiogenesis in hematologic malignancies", Crit. Rev. Oncol. Hematol. 45, 227–244.
   PubMed Web of Science ®Google Scholar
• Seidl, S., Kaufmann, H. and Drach, J. (2003) "New insights into the pathophysiology of multiple myeloma", Lancet Oncol. 4, 557–564.
   PubMed Web of Science ®Google Scholar
• Vacca, A., Ribatti, D., Roccaro, A.M., Frigeri, A. and Dammacco, F. (2001) "Bone marrow angiogenesis in patients with active multiple myeloma", Semin. Oncol. 28, 543–550.
   PubMed Web of Science ®Google Scholar
• Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, E and Dammacco, E (1999) "Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma", Blood 93, 3064–3073.
   PubMed Web of Science ®Google Scholar
• Rajkumar, S.V., Mesa, A., Fonseca, R., Schroeder, G., Plevak, M.F., Dispenzieri, A., Lacy, M.Q., Lust, J.A., Witzig, T.E., Gertz, M.A., Kyle, R.A., Russell, S.J. and Greipp, P.R. (2002) "Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple mye-loma, and primary amyloidosis", Clin. Cancer Res. 8, 2210–2216.
   PubMed Web of Science ®Google Scholar
• Munshi, N.C. and Wilson, C. (2001) "Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis", Semin. Oncol. 28, 65–69.
   Web of Science ®Google Scholar
• Pruned, G., Ponzoni, M., Ferreri, A.J., Decarli, N., Tresoldi, M., Raggi, E, Baldessari, C., Freschi, M., Baldini, L., Goldaniga, M., Neri, A., Carboni, N., Bertolini, F. and Viale, G. (2002) "Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients", Br. J. Haematol. 118, 817–820.
   PubMed Web of Science ®Google Scholar
• Asosingh, K., de Raeve, H., Menu, E., Van Riet, I., Van Marck, E., Van Camp, B. and Vanderkerken, K. (2004) "Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity", Blood 103, 3131–3137.
   PubMed Web of Science ®Google Scholar
• Bellamy, W.T. (2001) "Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies", Semin. Oncol. 28, 551–559.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Witzig, T.E., Timm, M., Haug, J., Wellik, L., Fonseca, R., Greipp, P.R. and Rajkumar, S.V. (2003) "Expression of VEGF and its receptors by myeloma cells", Leukemia 17, 2025–2031.
   PubMed Web of Science ®Google Scholar
• Ria, R., Roccaro, A.M., Merchionne, E, Vacca, A., Dammacco, F. and Ribatti, D. (2003) "Vascular endothelial growth factor and its receptors in multiple myeloma", Leukemia 17, 1961–1966.
   PubMed Web of Science ®Google Scholar
• Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., Serve, H., Berdel, W.E. and Kienast, J. (2000) "Vascular endothelial growth factor and interleuldn-6 in paracrine tumor-stromal cell interactions in multiple mye-loma", Blood 95, 2630–2636.
   PubMed Web of Science ®Google Scholar
• Gupta, D., Treon, SE, Shima, Y., Hideshima, T., Podar, K., Tai, YT., Lin, B., Lentzsch, S., Davies, ER, Chauhan, D., Schlossman, R.L., Richardson, E, Ralph, P., Wu, L., Payvandi, E, Muller, G., Stirling, DJ. and Anderson, K.C. (2001) "Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications", Leukemia 15, 1950–1961.
   PubMed Web of Science ®Google Scholar
• Podar, K., Tai, Y.T., Davies, EE., Lentzsch, S., Sattler, M., Hideshima, T., Lin, B.K., Gupta, D., Shima, Y, Chauhan, D., Mitsiades, C., Raje, N., Richardson, P. and Anderson, K.C. (2001) "Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration", Blood 98, 428–435.
   PubMed Web of Science ®Google Scholar
• Giuliani, N., Lunghi, P., Morandi, E, Colla, S., Bonomini, S., Hojden, M., Rizzoli, V. and Bonati, A. (2004) "Down-modulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis", Leukemia 18, 628–635.
   PubMed Web of Science ®Google Scholar
• Giuliani, N., Colla, S., Morandi, E, Lazzaretti, M., Mancini, C. and Rizzoli, V. (2003) "Angiogenic switch in multiple myeloma patients", Blood 102, 441a.
   Web of Science ®Google Scholar
• Di Raimondo, E, Azzaro, M.P., Palumbo, G., Bagnato, S., Giustolisi, G., Floridia, P., Sortino, G. and Giustolisi, R. (2000) "Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood", Haematologica 85, 800–805.
   PubMed Web of Science ®Google Scholar
• Bisping, G., Leo, R., Wenning, D., Dankbar, B., Padro, T., Kropff, M., Scheffold, C., Kroger, M., Mesters, R.M., Berdel, W.E. and Kienast, J. (2003) "Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma", Blood 101, 2775–2783.
   PubMed Web of Science ®Google Scholar
• Colla, S., Morandi, F., Lazzaretti, M., Polistena, P., Svaldi, M., Coser, P., Bonomini, S., Hojden, M., Martella, E., Chisesi, T., Rizzoli, V. and Giuliani, N. (2003) "Do human myeloma cells directly produce basic FGF?", Blood 102, 3071–3072.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Witzig, T.E., Timm, M., Haug, J., Wellik, L., Kimlinger, T.K., Greipp, P.R. and Rajkumar, S.V. (2004) "Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression", Blood 104, 1159–1165.
   PubMed Web of Science ®Google Scholar
• Giuliani, N., Colla, S., Lazzaretti, M., Sala, R., Roti, G., Mancini, C., Bonomini, S., Lunghi, P., Hojden, M., Genestreti, G., Svaldi, M., Coser, P., Fattori, PP., Sammarelli, G., Gazzola, G.C., Bataille, R., Almici, C., Caramatti, C., Mangoni, L. and Rizzoli, V. (2003) "Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis", Blood 102, 638–645.
   PubMed Web of Science ®Google Scholar
• Shapiro, VS., Mollenauer, M.N. and Weiss, A. (2001) "Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression", Blood 98, 187–193.
   PubMed Web of Science ®Google Scholar
• Borset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. and Waage, A. (1996) "Hepatocyte growth factor and its receptor c-met in multiple myeloma", Blood 88, 3998–4004.
   PubMed Web of Science ®Google Scholar
• Saeki, Y, Mima, T., Ishii, T., Ogata, A., Kobayashi, H., Ohshima, S., Ishida, T., Tabunoki, Y., Kitayama, H., Mizuki, M., Katada, Y., Asaoku, H., Kitano, M., Nishimoto, N., Yoshizald, K., Maeda, M., Kon, S., Kinoshita, N., Uede, T. and Kawase, I. (2003) "Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications", Br. J. Haematol. 123, 263–270.
   PubMed Web of Science ®Google Scholar
• Portier, M., Zhang, X.G., Ursule, E., Lees, D., Jourdan, M., Bataille, R. and Klein, B. (1993) "Cytokine gene expression in human multiple myeloma", Br. J. Haematol. 85, 514–520.
   PubMed Web of Science ®Google Scholar
• Hedvat, CV., Comenzo, R.L., Teruya-Feldstein, J., Olshen, A.B., Ely, S.A., Osman, K., Zhang, Y., Kalakonda, N. and Nimer, S.D. (2003) "Insights into extramedullary tumour cell growth revealed by expression profiling of human plasma-cytomas and multiple myeloma", Br. J. Haematol. 122, 728–744.
   PubMed Web of Science ®Google Scholar
• Munshi, N.C., Hideshima, T., Carrasco, D., Shammas, M., Auclair, D., Davies, E, Mitsiades, N., Mitsiades, C., Kim, R.S., Li, C., Rajkumar, S.V., Fonseca, R., Bergsagel, L., Chauhan, D. and Anderson, K.C. (2004) "Identification of genes modu-lated in multiple myeloma using genetically identical twin samples", Blood 103, 1799–1806.
   PubMed Web of Science ®Google Scholar
• Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P.S. and Peters, K. (1997) "Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth", J. Clin. Invest. 100, 2072–2078.
   PubMed Web of Science ®Google Scholar
• Vacca, A., Ria, R., Semeraro, E, Merchionne, E, Coluccia, M., Boccarelli, A., Scavelli, C., Nico, B., Gernone, A., Battelli, F., Tabilio, A., Guidolin, D., Petrucci, MT., Ribatti, D. and Dammacco, E (2003) "Endothelial cells in the bone marrow of patients with multiple myeloma", Blood 102, 3340–3348.
   PubMed Web of Science ®Google Scholar